AirMed and Cannabis 2.0
In our last post, we discussed how Cannabis 2.0 is changing the Canadian cannabis industry, but how does AirMed power this product innovation?
With the legalization of derivative products like edibles, vapes, and topicals, a world of opportunity has opened up for licensed producers. To thrive in this evolving market, Canadian companies—from large-scale operations to nimble micro-processors—need a flexible cannabis management system. This is where AirMed comes in BY providing a comprehensive solution designed to handle the complexities of Cannabis 2.0 while ensuring compliance every step of the way.
Meeting the Unique Challenges of Cannabis 2.0
Producing derivative cannabis products is more complex than simply growing and packaging dried flower. It involves intricate manufacturing processes, strict quality control, and detailed record-keeping. AirMed software is specifically designed to handle these challenges.
Manufacturing and Processing: AirMed offers unique workflows for each product type, from edibles and beverages to vapes and concentrates. The system tracks every step of your production process, from sourcing raw materials to extraction and final packaging. This ensures you have a complete audit trail for Health Canada inspections.
Inventory and Batch Tracking: With Cannabis 2.0 products, precision is everything. AirMed tracks weights to five decimal places and allows you to manage batches and lots with unique identifiers. This is critical for maintaining consistency and accuracy, especially with products that have a regulated THC and CBD content per package. Our software supports the creation of discrete units like pre-rolls and gel caps, as well as bulk products for sale to other licensed producers.
Compliance and Reporting: The regulations for Cannabis 2.0 products are extensive, covering everything from ingredient lists to packaging requirements and THC limits. AirMed automates the data collection for Health Canada’s Cannabis Tracking and Licensing System (CTLS) reports, simplifying the compliance process. Our software ensures you can meet all federal, provincial, and even international standards (like the USA’s FDA 21 CFR Part 11 and EU GMP).
The Bottom Line: A Solution to Cultivate Success
The Cannabis 2.0 market is driven by consumer demand for diverse and innovative products. By using AirMed, Canadian licensed producers can streamline their operations, reduce compliance risks, and focus on what they do best: creating high-quality cannabis products.
Whether you are a large-scale standard processor introducing a new line of infused products or a micro-cultivator crafting artisanal strains, the AirMed platform offers the tools you need. Our software provides the foundation of efficiency and control needed to not only survive but to thrive in this exciting new chapter of the Canadian cannabis industry.
To learn more about how AirMed powers Cannabis 2.0 innovation for Canadian producers, visit our Software page.
Cannabis 2.0 in Canada
“Cannabis 2.0” describes the expansion of the legal Canadian cannabis market beyond the initial offerings of dried flower, oils, and seeds. This new era is the result of the legalization of derivative products like edibles, vapes, beverages, topicals, and concentrates in Canada, which happened back in 2019. The shift has been significant in the Canadian industry, as it has attracted a new segment of consumers who may not be interested in smoking or vaping.
Consumer Behavior
Initially, dried flower dominated the cannabis market, but consumer tastes are evolving. New users in particular are seeking discreet, convenient, and predictable ways to consume cannabis. Cannabis 2.0 products directly address this demand. Edibles like gummies and chocolates as well as ready-to-drink beverages offer a familiar format, making them appealing to those who were previously hesitant to try cannabis. This trend is causing a gradual decline in the market share of dried flower, while other categories, especially vapes and edibles, are seeing significant growth.
Product Innovation and Market Diversification
The rise of Cannabis 2.0 has sparked a wave of innovation. Canadian licensed producers are developing a wide variety of products with different cannabinoid profiles (THC, CBD, and CBN) and terpene blends. This lets them create products with targeted effects, such as those for relaxation, sleep, or creativity. Some of the most exciting innovations include:
- Fast-acting edibles and beverages: Technology has been developed to create products that deliver effects much faster than traditional edibles, which often took hours to kick in. This is a game-changer for consumer experience and predictability.
- Minor cannabinoid products: Beyond THC and CBD, producers are now creating products that highlight minor cannabinoids like CBN (cannabinol) for sleep, or CBG (cannabigerol) for its anti-inflammatory properties.
- Craft and gourmet products: The market is seeing a rise in high-end, carefully crafted products, such as artisanal chocolates and specialty beverages, that are designed to compete with premium mainstream goods.
Attracting a Broader Audience
The diverse product offerings of Cannabis 2.0 are helping to destigmatize cannabis use and attract new customers. Many consumers who are not traditional cannabis users are drawn to topicals for pain relief, beverages as an alternative to alcohol, or low-dose edibles for a gentle introduction.
This expansion of the consumer base is vital for the long-term health and growth of the legal industry. It’s moving cannabis out of the shadows and into the mainstream, positioning it as a lifestyle product for a variety of purposes and demographics.
For more information visit our Software page.